Nottingham, United Kingdom

Zoe Elizabeth Barter

USPTO Granted Patents = 3 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Zoe Elizabeth Barter

Introduction

Zoe Elizabeth Barter is a prominent inventor based in Nottingham, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatment regimens involving maribavir. With a total of 3 patents to her name, her work is paving the way for advancements in drug interactions and dosing strategies.

Latest Patents

Zoe's latest patents focus on the use of maribavir in treatment regimens. The characterization of drug-drug interaction properties and pharmacological properties of maribavir is crucial for informing potential drug-drug interactions and optimizing dosing strategies when administering it alongside co-medications. This innovative approach highlights her commitment to improving patient outcomes through careful research and development.

Career Highlights

Zoe is currently employed at Takeda Pharmaceutical Company Limited, where she continues to push the boundaries of pharmaceutical research. Her work is characterized by a dedication to understanding complex drug interactions, which is essential for the safe and effective use of medications in clinical settings.

Collaborations

Throughout her career, Zoe has collaborated with notable colleagues such as Kefeng Sun and Matthew Crouthamel. These partnerships have enriched her research and contributed to the successful development of her patents.

Conclusion

Zoe Elizabeth Barter's innovative work in the pharmaceutical industry exemplifies the impact of dedicated research on drug development. Her contributions are vital for enhancing treatment regimens and ensuring patient safety in medication administration.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…